Release Date: 15/08/14 16:00 Summary: Announcement of buy-back - Appendix 3C Price Sensitive: Yes Download Document 101.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%